clonoSEQ: What is MRD

The clonoSEQ® Assay is a highly accurate, sensitive and standardized method for detecting and quantifying MRD, or measurable residual disease, in lymphoid malignancies such as myeloma, ALL, CLL and NHL. Watch this video to learn more about clonoSEQ and how it can be used by clinicians to assess and monitor a patient’s disease burden over time.
Learn more at www.adaptivebi...